PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-12-07 (1)

Date Title Company
07-Dec-2025 Star Therapeutics Presents Interim Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease, Demonstrating Substantial Bleed Reductions in All Patients, at ASH Annual Meeting Businesswire